SCHEMBL5111290

SCHEMBL5111290

CC(=O)Nc1cccc(COc2c(Cl)cc(CC(=O)O)cc2Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 1/20 0.52
USP2 O75604 1/20 0.49
SENP5 Q96HI0 1/20 0.49
SENP2 Q9HC62 1/20 0.49
SENP1 Q9P0U3 1/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
SIRT2 Q8IXJ6 1/20 0.48
SIRT3 Q9NTG7 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.46
MAOB P27338 1/20 0.46
THRA P10827 2/20 0.46
THRB P10828 2/20 0.46
LMNA P02545 1/20 0.46
SELP P16109 1/20 0.45
SELE P16581 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PDE5A O76074 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722563 0.90 SENP5 (0.46) CLCN2USP2SENP5SENP2SENP1
SCHEMBL5110110 0.88 SLC1A2 (0.51) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4358744 0.88 THRA (0.60) CLCN2USP2SENP5SENP2SENP1
SCHEMBL5119092 0.88 THRB (0.59) USP2SENP5SENP2SENP1MEN1
SCHEMBL4929427 0.88 THRA (0.47) MEN1KMT2AMRGPRX4RAB9ANPC1
SCHEMBL5104534 0.87 THRA (0.52) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4930325 0.87 THRA (0.45) CLCN2KMT2AMRGPRX4THRATHRB
SCHEMBL4932778 0.86 THRB (0.62) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5104149 0.85 THRB (0.44) CLCN2MEN1KMT2AMRGPRX4THRA
SCHEMBL5109969 0.84 THRB (0.43) CLCN2USP2SENP5SENP2SENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA CLCN2 1806/4885USP2 4150/4885SENP5 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.